EP 1773791 A4 20090826 - PYRROLOTRIAZINE COMPOUNDS
Title (en)
PYRROLOTRIAZINE COMPOUNDS
Title (de)
PYRROLOTRIAZINVERBINDUNGEN
Title (fr)
COMPOSES PYRROLOTRIAZINE
Publication
Application
Priority
- US 2005022059 W 20050622
- US 58476804 P 20040701
Abstract (en)
[origin: US7102003B2] The present invention provides compounds of formula I and pharmaceutically acceptable salts thereof. The compounds of the invention inhibit tyrosine kinase activity of growth factor receptors such as HER1, HER2 and HER4 thereby making them useful as antiproliferative agents. The compounds are also useful for the treatment of other diseases associated with signal transduction pathways operating through growth factor receptors.
IPC 8 full level
C07D 487/04 (2006.01); A61K 31/53 (2006.01); A61P 35/00 (2006.01); A61P 35/04 (2006.01)
CPC (source: EP US)
A61P 35/00 (2018.01 - EP); A61P 35/04 (2018.01 - EP); C07D 487/04 (2013.01 - EP US)
Citation (search report)
- [Y] WO 0071129 A1 20001130 - BRISTOL MYERS SQUIBB CO [US]
- [Y] WO 03042172 A2 20030522 - BRISTOL MYERS SQUIBB CO [US], et al
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR
Designated extension state (EPC)
HR LV MK YU
DOCDB simple family (publication)
US 2006014745 A1 20060119; US 7102003 B2 20060905; AT E482212 T1 20101015; DE 602005023732 D1 20101104; EP 1773791 A1 20070418; EP 1773791 A4 20090826; EP 1773791 B1 20100922; ES 2350697 T3 20110126; WO 2006007468 A1 20060119
DOCDB simple family (application)
US 15746005 A 20050621; AT 05763768 T 20050622; DE 602005023732 T 20050622; EP 05763768 A 20050622; ES 05763768 T 20050622; US 2005022059 W 20050622